The 2025 Synthetic Data Summit, taking place on May 16, 2025 at the Centre PHI in Montreal, will explore how synthetic data is being used to address real-world data challenges and privacy problems of data access and sharing, and examine its future applications in healthcare.
“Synthetic data generation (SDG) is a powerful privacy enhancing technology (PET) and modern method for de-identification that is solving some of the toughest challenges in healthcare data access and data analytics,” said Dr. Khaled El Emam, Director of the Electronic Health Information Laboratory (EHIL), one of the organizers of the event. A globally recognized expert in de-identification, Dr. El Emam is also a professor at the University of Ottawa’s School of Epidemiology and Public Health. He has spent decades developing PETs and advancing methods for securely sharing health data.
“By using AI to create high-quality datasets that do not contain personal information, SDG enables data to be shared and analyzed, protecting privacy. SDG also helps amplify and fill gaps in datasets to improve research outcomes, as well as reduce bias in clinical trials and real-world evidence studies. The 2025 Summit is a unique opportunity to gain a well-rounded perspective on how synthetic data is transforming healthcare now, and in the years ahead.”
With an emphasis on practical solutions, case studies, regulatory considerations, adoption strategies, and future developments, the Summit will feature expert speakers from across industry, government, academia, and regulatory agencies. Topics will include:
- Exploring how synthetic data is being applied in clinical trials, real-world evidence studies, and healthcare analytics
- Examining privacy risks in synthetic datasets and approaches for evaluating and addressing any vulnerabilities
- Demonstrating how synthetic data can augment structured health datasets to improve research outcomes
- Learning about regulatory perspectives and evolving policies and standards shaping the adoption of synthetic data in healthcare, life sciences, and beyond
Visit the full program and registration information.
About the sponsors:
Aetion
Aetion® is a global healthcare technology company delivering real-world evidence (RWE) solutions to biopharma, medical device manufacturers, payers, and regulators. Headquartered in New York, Aetion applies validated epidemiologic methods, causal inference, and structured analytics to transform real-world data (RWD) into decision-grade insights. Aetion Evidence Platform® (AEP) supports predictive analytics, personalized treatment strategies, and scalable solutions for regulatory submissions, market access, and clinical development. Recognized for scientific rigour and transparency, Aetion delivers regulator-accepted evidence on the safety, effectiveness, and value of medical treatments—enabling healthcare leaders to shape the future of medicine. Learn more at aetion.com and follow us on LinkedIn.
MDClone
MDClone empowers healthcare organizations to reimagine what’s possible by enabling meaningful dialogue with granular clinical information. Leaders and teams across all levels harness speed, scale, and collaboration to drive transformative change in quality, operations, and research—delivering measurable value today, not tomorrow. Our ADAMS technology and methodology includes granular data exploration and multilevel synthetic privacy capabilities that empower any level of an organization to engage in a dynamic and fluid process for data exploration, analysis, and action. MDClone customers are accelerating research, improving operations and quality, and driving value creation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, the UK, Switzerland, Brazil, and Israel. Visit mdclone.com for more information.
CHEO Research Institute
The CHEO Research Institute is a global centre of excellence in pediatric research that connects talent and technology in pursuit of life-changing research for every child, youth, and family in the CHEO community and beyond. The CHEO Research Institute coordinates the research activities of CHEO and is affiliated with the University of Ottawa. At the CHEO Research Institute, discoveries inspire the best life for every child and youth. For more information, visit cheoresearch.ca.